CC

Commodore Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 73.3%
This Quarter Est. Return
1 Year Est. Return
+73.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.36B
AUM Growth
-$7.47M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$64M
2
+$58.1M
3
+$25.6M
4
MRUS icon
Merus
MRUS
+$25.2M
5
SLDB icon
Solid Biosciences
SLDB
+$21.6M

Top Sells

1
+$26.8M
2
+$13.9M
3
+$11.6M
4
ABVX
Abivax
ABVX
+$9.4M
5
BBOT
BridgeBio Oncology
BBOT
+$5.25M

Sector Composition

1 Healthcare 99.43%
2 Financials 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGNE icon
26
Neurogene
NGNE
$430M
$10.8M 0.8%
925,000
+125,000
TYRA icon
27
Tyra Biosciences
TYRA
$759M
$8.84M 0.65%
+950,000
PCSC
28
Perceptive Capital Solutions
PCSC
$7.72M 0.57%
750,000
CELC icon
29
Celcuity
CELC
$3.04B
$7.03M 0.52%
695,650
+295,650
VTGN icon
30
VistaGen Therapeutics
VTGN
$125M
$3.94M 0.29%
1,575,000
AVTX icon
31
Avalo Therapeutics
AVTX
$316M
$3.87M 0.29%
483,000
ABVX
32
Abivax
ABVX
$7.12B
– –
-1,284,110
NKTX icon
33
Nkarta
NKTX
$175M
– –
-351,848
THRD
34
DELISTED
Third Harmonic Bio
THRD
– –
-237,704
BBOT
35
BridgeBio Oncology
BBOT
$864M
– –
-500,000
1
2